Here are the top stories from the last week:

CDC’s Autism Statement Sparks New Concerns Over Vaccine Safety Messaging
The CDC's website update retracting the statement that vaccines do not cause autism contradicts decades of research showing no link between vaccines and autism.
Read article »

FDA Approves First Fibromyalgia Treatment in 15 Years
The approval allows Tonix to move forward and market the first-in-class, nonopioid, once-daily bedtime analgesic with a unique sublingual formulation aimed at providing rapid absorption into the bloodstream for patients with fibromyalgia.
Read article »

Novo Nordisk cuts prices on Wegovy and Ozempic
Novo Nordisk has reduced the prices of its popular weight-loss and diabetes drugs, Wegovy and Ozempic, from $499 to $349 per month. This decision follows pressure from the Trump administration to lower drug costs. The company also offers an introductory price of $199 for the first two months for new customers.
Read article »

ERIC urges USPTO to withdraw patent rule that weakens competition, raises drug costs
The ERISA Industry Committee (ERIC) is urging the U.S. Patent and Trademark Office to withdraw a proposed rule that revises procedures of the Patent Trial and Appeal Board. ERIC argues that the rule weakens the patent review process, raises prescription drug costs, and contradicts the administration's pro-competition agenda.
Read article »

Finding the Right CPT Codes Is the Backbone of 2026 Payments
New codes include those for shorter-duration remote patient monitoring, augmentative and assistive artificial intelligence services, hearing device services, a procedure known as a leg revascularization revision, and updated appendixes.
Read article »

Nature's Truth named No. 1 Vitamin Brand in Independent Pharmacy for fifth straight year
Nature's Truth has been named the top vitamin brand in Independent Pharmacy for the fifth consecutive year. The brand has seen growth in several subcategories, including Single Letter Vitamins and Mineral Supplements, and has expanded its brand portfolio with new acquisitions.
Read article »

RSV in Older Adults: Recognizing Risk Factors and Missed Opportunities for Vaccination
New RSV vaccines for older adults enhance prevention efforts, yet awareness and uptake remain low. Pharmacists play a crucial role in improving vaccination rates.
Read article »

Virtual Escape Rooms for Emergency Preparedness: Pharmacists Innovate Training Through Gamified Learning
Emergency medicine pharmacists discuss how they used a gamified, PowerPoint-based virtual escape room to improve disaster preparedness training, strengthen critical thinking, and highlight the essential role of pharmacists in emergency management.
Read article »

NACDS submits statement on Senate Finance hearing on the rising cost of health care
The National Association of Chain Drug Stores (NACDS) submitted a statement to the U.S. Senate Committee on Finance, emphasizing the need for pharmacy benefit manager (PBM) reform to lower drug costs and prevent pharmacy closures. The statement supports the "Ensuring Community Access to Pharmacist Services Act" to expand care for seniors.
Read article »

Diabetes Care Roundtable 2025: Making the most of Rx in diabetes care
The article discusses the evolving role of pharmacies in managing diabetes, highlighting the use of continuous glucose monitors (CGMs) and GLP-1 medications. It emphasizes the importance of pharmacists in chronic disease management and the challenges of billing CGMs to Medicare Part B.
Read article »

‍

‍

‍

‍